within Pharmacolibrary.Drugs.ATC.L;

model L01BB07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.7166666666666667,
    adminDuration  = 600,
    adminMass      = 1.5,
    adminCount     = 1,
    Vd             = 0.048,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Nelarabine is a prodrug of the deoxyguanosine analogue ara-G, approved for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in both pediatric and adult patients. It is used when the disease has not responded to, or has relapsed following, at least two chemotherapy regimens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adults and pediatric patients with refractory or relapsed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma following intravenous administration.</p><h4>References</h4><ol><li><p>Dyakonova, YY, et al., &amp; Karachunskiy, AI (2018). The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience. <i>Terapevticheskii arkhiv</i> 90(7) 38–50. DOI:<a href=&quot;https://doi.org/10.26442/terarkh201890738-50&quot;>10.26442/terarkh201890738-50</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30701921/&quot;>https://pubmed.ncbi.nlm.nih.gov/30701921</a></p></li><li><p>Kurtzberg, J, et al., &amp; Mitchell, BS (2005). Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. <i>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</i> 23(15) 3396–3403. DOI:<a href=&quot;https://doi.org/10.1200/JCO.2005.03.199&quot;>10.1200/JCO.2005.03.199</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15908652/&quot;>https://pubmed.ncbi.nlm.nih.gov/15908652</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01BB07;
